Search
for

    Glossary Fulvestrant

    medication that blocks estrogen receptors to treat breast cancer

    Fulvestrant, also known by the brand name Faslodex, is a medication used to treat certain types of breast cancer. It works by blocking and degrading estrogen receptors on cancer cells, which can slow or stop the growth of tumors that rely on estrogen to grow.

    Research 9 of 74

    1. Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents Annals of Oncology · 2005 · 67 citations
    2. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies British Journal of Dermatology · 2007 · 6 citations
    3. Oestrogen receptor antagonist and hair regrowth in dogs with hair cycle arrest (alopecia X) Veterinary dermatology · 2007 · 11 citations
    4. Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq” Journal of cancer research updates · 2026
    5. Incidence of alopecia from endocrine therapies in cancer Journal of The American Academy of Dermatology · 2013
    6. Onychomatricoma with classic features: Case report and review of the literature Journal of The American Academy of Dermatology · 2013
    7. An estrogen receptor pathwayregulates thetelogen-anagen hair follicle transition andinfluences epidermal cell proliferation (epidermis/estrogen/keratinocyte/differentiation/mesenchymal 1996
    8. Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion npj Breast Cancer · 2025
    9. Hormone Blocking Anticancer Drugs 2015
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →